Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect.

Riggs, Julie M; Charya, Ananth V; Eberlein, Michael H; Reed, Robert M; Saharia, Kapil K

Riggs, Julie M; Charya, Ananth V; Eberlein, Michael H; Reed, Robert M; Saharia, Kapil K.

Afiliação

Riggs JM; Program in Transplantation, University of Maryland Medical Center, Baltimore, Maryland, USA. Electronic address: jriggs@umm.edu.
Charya AV; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Eberlein MH; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Reed RM; Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Saharia KK; Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Am J Transplant ; 23(3): 450, 2023 03.

Article em En | MEDLINE | ID: mdl-36695703

Assuntos

Transplante de Órgãos; Profilaxia Pré-Exposição; Humanos; Infecções Irruptivas; Transplantados

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Órgãos / Profilaxia Pré-Exposição Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Am J Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google